Reevaluating First-line Therapies in Youth-Onset Type 2 Diabetes

被引:2
作者
Chung, Stephanie T. [1 ,2 ,3 ]
Davis, Faith [1 ]
Patel, Tejal [2 ]
Mabundo, Lilian [1 ]
Estrada, Doris E. [2 ]
机构
[1] Natl Inst Diabet & Digest & Kidney Dis, Sect Pediat Diabet Obes & Metab, NIH, Bethesda, MD 20892 USA
[2] Childrens Natl Hosp, Div Endocrinol & Diabet, Washington, DC 20010 USA
[3] Natl Inst Diabet & Digest & Kidney Dis, NIH, 10 Ctr Dr, Bld 10-CRC,RM 5-5942, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
pediatric; type; 2; diabetes; medication; metformin; treatment;
D O I
10.1210/clinem/dgad508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of youth-onset type 2 diabetes is growing worldwide and current first-line treatment with metformin and intensive behavior and lifestyle changes are suboptimal in over 50% of youth within 2 years of diagnosis. This perspective article is a call to action for reevaluation of existing strategies and critical appraisal of metformin as first-line therapy in youth-onset type 2 diabetes. Increased attention should be given to novel therapeutics approved in youth, including glucagon-like 1 receptor agonists, sodium glucose cotransporter-2, and sociocultural interventions that will promote diabetes self-management.
引用
收藏
页码:e870 / e872
页数:3
相关论文
共 50 条
  • [31] Pancreatic Lipid Content Is Not Associated with Beta Cell Dysfunction in Youth-Onset Type 2 Diabetes
    Wicklow, Brandy A.
    Griffith, Angella T.
    Dumontet, Jacqueline N.
    Venugopal, Niranjan
    Ryner, Lawrence N.
    McGavock, Jonathan M.
    CANADIAN JOURNAL OF DIABETES, 2015, 39 (05) : 398 - 404
  • [32] Deterioration of Glycemic Control in Youth-Onset Type 2 Diabetes: What Are the Early and Late Predictors?
    Zeitler, Philip
    El Ghormli, Laure
    Arslanian, Silva
    Caprio, Sonia
    Isganaitis, Elvira
    Kelsey, Megan K.
    Weinstock, Ruth S.
    White, Neil H.
    Drews, Kimberly
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08) : E3384 - E3394
  • [33] Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes
    Chen, Zsu-Zsu
    Lu, Chang
    Dreyfuss, Jonathan M.
    Tiwari, Gaurav
    Shi, Xu
    Zheng, Shuning
    Wolfs, Danielle
    Pyle, Laura
    Bjornstad, Petter
    El Ghormli, Laure
    Gerszten, Robert E.
    Isganaitis, Elvira
    DIABETES CARE, 2024, 47 (09) : 1597 - 1607
  • [34] Incidence of long-term diabetes complications and mortality in youth-onset type 2 diabetes: A systematic review
    Fan, Yingnan
    Lau, Eric S. H.
    Wu, Hongjiang
    Yang, Aimin
    Chow, Elaine
    So, Wing-Yee
    Kong, Alice P. S.
    Ma, Ronald C. W.
    Chan, Juliana C. N.
    Luk, Andrea O. Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
  • [35] Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study
    Pinto, Cathy A.
    Stafford, Jeanette M.
    Wang, Tongtong
    Shankar, R. Ravi
    Lawrence, Jean M.
    Kim, Grace
    Pihoker, Catherine
    D'Agostino, Ralph B., Jr.
    Dabelea, Dana
    PEDIATRIC DIABETES, 2018, 19 (06) : 1065 - 1072
  • [36] Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
    March, Christine A.
    Becker, Dorothy J.
    Libman, Ingrid M.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [37] Trajectories in estimated glomerular filtration rate in youth-onset type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study
    Westreich, Katherine D.
    Isom, Scott
    Divers, Jasmin
    D'Agostino, Ralph
    Lawrence, Jean M.
    Shankar, Roopa Kanakatti
    Dolan, Lawrence M.
    Imperatore, Giuseppina
    Dabelea, Dana
    Mayer-Davis, Elizabeth J.
    Mottl, Amy K.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (02)
  • [38] Should metformin remain the first-line therapy for treatment of type 2 diabetes?
    Baker, Chelsea
    Retzik-Stahr, Cimmaron
    Singh, Vatsala
    Plomondon, Renee
    Anderson, Victoria
    Rasouli, Neda
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [39] Cardiovascular Comorbidity Associated With Albuminuria in Youth-Onset Type 2 Diabetes: Analyses From the iCARE Study
    Sellers, Elizabeth A. C.
    Dart, Allison B.
    McGavock, Jonathan
    Wicklow, Brandy A.
    CANADIAN JOURNAL OF DIABETES, 2021, 45 (05) : 458 - 465
  • [40] Plasma neurofilament light chain concentrations are elevated in youth-onset type 2 diabetes and associated with neuropathy
    Fridman, Vera
    Sillau, Stefan
    Ritchie, Alanna
    Bockhorst, Jacob
    Coughlan, Christina
    Araya, Paula
    Espinosa, Joaquin M.
    Smith, Keith
    Lange, Ethan M.
    Lange, Leslie A.
    Ghormli, Laure El
    Drews, Kimberly L.
    Zeitler, Philip
    Reusch, Jane E. B.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 (03) : 460 - 470